Biodesix Inc
BDSX- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001439725
In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Biodesix Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 30 | 29 | −1 |
| Shares | 16.7M | 16.8M | +174.9K (+1.0%) |
| Value | $31.0M | $20.7M | −$10.3M (−33.2%) |
New holders (4)
Institutions that held Biodesix Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 13,178 | $16.2K | 0.00% |
| Barclays PLC | 247 | $304 | 0.00% |
| Gradient Investments LLC | 100 | $123 | 0.00% |
| Simplex Trading, LLC | 95 | $0 | 0.00% |
Sold out (5)
Institutions that held Biodesix Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Endurant Capital Management LP | 113,267 | $210.7K |
| Susquehanna International Group, LLP | 36,815 | $68.5K |
| HRT Financial LP | 32,890 | $61.0K |
| Bank of America Corp | 303 | $564 |
| Tower Research Capital LLC (TRC) | 34 | $0 |